117 related articles for article (PubMed ID: 36755523)
1. Multiplicative, additive, and interactive associations of 25-hydroxyvitamin D with lung and prostate cancer.
Voutilainen A; Virtanen JK; Hantunen S; Nurmi T; Kokko P; Tuomainen TP
Int J Vitam Nutr Res; 2024 Apr; 94(2):133-142. PubMed ID: 36755523
[No Abstract] [Full Text] [Related]
2. How competing risks affect the epidemiological relationship between vitamin D and prostate cancer incidence? A population-based study.
Voutilainen A; Virtanen JK; Hantunen S; Nurmi T; Kokko P; Tuomainen TP
Andrologia; 2022 Jul; 54(6):e14410. PubMed ID: 35229338
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men.
McGrowder D; Tulloch-Reid MK; Coard KCM; McCaw-Binns AM; Ferguson TS; Aiken W; Harrison L; Anderson SG; Jackson MD
Cancer Control; 2022; 29():10732748221131225. PubMed ID: 36180132
[TBL] [Abstract][Full Text] [Related]
4. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
5. In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer.
Wong YY; Hyde Z; McCaul KA; Yeap BB; Golledge J; Hankey GJ; Flicker L
PLoS One; 2014; 9(6):e99954. PubMed ID: 24949795
[TBL] [Abstract][Full Text] [Related]
6. Both serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry.
Jackson MD; Tulloch-Reid MK; Lindsay CM; Smith G; Bennett FI; McFarlane-Anderson N; Aiken W; Coard KC
Cancer Med; 2015 Jun; 4(6):925-35. PubMed ID: 25858172
[TBL] [Abstract][Full Text] [Related]
7. Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Mondul AM; Lindström S; Tsilidis KK; Travis RC; Gerke T; Albanes D; Mucci LA; Giovannucci E; Kraft P;
Cancer; 2015 Jun; 121(12):1949-56. PubMed ID: 25731953
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
9. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
[TBL] [Abstract][Full Text] [Related]
10. Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.
Dimitrakopoulou VI; Travis RC; Shui IM; Mondul A; Albanes D; Virtamo J; Agudo A; Boeing H; Bueno-de-Mesquita HB; Gunter MJ; Johansson M; Khaw KT; Overvad K; Palli D; Trichopoulou A; Giovannucci E; Hunter DJ; Lindström S; Willett W; Gaziano JM; Stampfer M; Berg C; Berndt SI; Black A; Hoover RN; Kraft P; Key TJ; Tsilidis KK
Am J Epidemiol; 2017 Mar; 185(6):452-464. PubMed ID: 28399564
[TBL] [Abstract][Full Text] [Related]
11. Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?
Murphy AB; Nyame YA; Batai K; Kalu R; Khan A; Gogana P; Dixon M; Macias V; Kajdacsy-Balla A; Hollowell CM; Catalona WJ; Kittles R
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):55-60. PubMed ID: 27725729
[TBL] [Abstract][Full Text] [Related]
12. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
13. A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
Travis RC; Perez-Cornago A; Appleby PN; Albanes D; Joshu CE; Lutsey PL; Mondul AM; Platz EA; Weinstein SJ; Layne TM; Helzlsouer KJ; Visvanathan K; Palli D; Peeters PH; Bueno-de-Mesquita B; Trichopoulou A; Gunter MJ; Tsilidis KK; Sánchez MJ; Olsen A; Brenner H; Schöttker B; Perna L; Holleczek B; Knekt P; Rissanen H; Yeap BB; Flicker L; Almeida OP; Wong YYE; Chan JM; Giovannucci EL; Stampfer MJ; Ursin G; Gislefoss RE; Bjørge T; Meyer HE; Blomhoff R; Tsugane S; Sawada N; English DR; Eyles DW; Heath AK; Williamson EJ; Manjer J; Malm J; Almquist M; Marchand LL; Haiman CA; Wilkens LR; Schenk JM; Tangen CM; Black A; Cook MB; Huang WY; Ziegler RG; Martin RM; Hamdy FC; Donovan JL; Neal DE; Touvier M; Hercberg S; Galan P; Deschasaux M; Key TJ; Allen NE
Cancer Res; 2019 Jan; 79(1):274-285. PubMed ID: 30425058
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological analysis of coronary heart disease and its main risk factors: are their associations multiplicative, additive, or interactive?
Voutilainen A; Brester C; Kolehmainen M; Tuomainen TP
Ann Med; 2022 Dec; 54(1):1500-1510. PubMed ID: 35603961
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
Ahn J; Albanes D; Berndt SI; Peters U; Chatterjee N; Freedman ND; Abnet CC; Huang WY; Kibel AS; Crawford ED; Weinstein SJ; Chanock SJ; Schatzkin A; Hayes RB;
Carcinogenesis; 2009 May; 30(5):769-76. PubMed ID: 19255064
[TBL] [Abstract][Full Text] [Related]
16. Effect of serum 25-hydroxyvitamin D level on lung, breast, colorectal and prostate cancers: a nested case-control study.
Acikgoz A; Cimrin D; Ergor G
East Mediterr Health J; 2020 Jul; 26(7):794-802. PubMed ID: 32794165
[TBL] [Abstract][Full Text] [Related]
17. Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the prostate testing for cancer and treatment study.
Gilbert R; Martin RM; Fraser WD; Lewis S; Donovan J; Hamdy F; Neal DE; Lane JA; Metcalfe C
Cancer Causes Control; 2012 Apr; 23(4):575-88. PubMed ID: 22382867
[TBL] [Abstract][Full Text] [Related]
18. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
Dimitrakopoulou VI; Tsilidis KK; Haycock PC; Dimou NL; Al-Dabhani K; Martin RM; Lewis SJ; Gunter MJ; Mondul A; Shui IM; Theodoratou E; Nimptsch K; Lindström S; Albanes D; Kühn T; Key TJ; Travis RC; Vimaleswaran KS; ; ; ; Kraft P; Pierce BL; Schildkraut JM
BMJ; 2017 Oct; 359():j4761. PubMed ID: 29089348
[No Abstract] [Full Text] [Related]
19. Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.
Gilbert R; Bonilla C; Metcalfe C; Lewis S; Evans DM; Fraser WD; Kemp JP; Donovan JL; Hamdy FC; Neal DE; Lane JA; Smith GD; Lathrop M; Martin RM
Cancer Causes Control; 2015 Feb; 26(2):205-218. PubMed ID: 25488826
[TBL] [Abstract][Full Text] [Related]
20. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.
Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
Cancer Causes Control; 2012 Nov; 23(11):1865-73. PubMed ID: 22926301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
